Free Trial

Hologic (HOLX) News Today

Hologic logo
$69.73 -0.24 (-0.34%)
As of 01/17/2025 04:00 PM Eastern
Hologic, Inc. stock logo
LaFleur & Godfrey LLC Increases Position in Hologic, Inc. (NASDAQ:HOLX)
LaFleur & Godfrey LLC boosted its position in shares of Hologic, Inc. (NASDAQ:HOLX - Free Report) by 2.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 130,373 shares of the medical equipment provider's stock after
Hologic, Inc. stock logo
Hologic, Inc. (NASDAQ:HOLX) Short Interest Update
Hologic, Inc. (NASDAQ:HOLX - Get Free Report) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 5,510,000 shares, an increase of 6.4% from the December 15th total of 5,180,000 shares. Based on an average daily trading volume, of 1,910,000 shares, the days-to-cover ratio is presently 2.9 days. Approximately 2.5% of the company's shares are short sold.
Hologic, Inc. stock logo
Avanza Fonder AB Purchases Shares of 25,810 Hologic, Inc. (NASDAQ:HOLX)
Avanza Fonder AB acquired a new position in shares of Hologic, Inc. (NASDAQ:HOLX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 25,810 shares of the medical equipment provider's stock, valued at approximat
Brokerages Set Hologic, Inc. (NASDAQ:HOLX) PT at $88.92
FDA Warns Hologic Over BioZorb Manufacturing Violations
Hologic: Reasonably, But Not Compellingly Valued
Hologic: Reasonably, But Not Compellingly Valued
Hologic, Inc. stock logo
Boston Common Asset Management LLC Sells 79,101 Shares of Hologic, Inc. (NASDAQ:HOLX)
Boston Common Asset Management LLC decreased its position in Hologic, Inc. (NASDAQ:HOLX - Free Report) by 25.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 227,564 shares of the me
Hologic, Inc. stock logo
Hologic, Inc. (NASDAQ:HOLX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Hologic, Inc. (NASDAQ:HOLX - Get Free Report) has received an average rating of "Moderate Buy" from the sixteen brokerages that are covering the company, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy
Hologic, Inc. stock logo
67,025 Shares in Hologic, Inc. (NASDAQ:HOLX) Bought by Benson Investment Management Company Inc.
Benson Investment Management Company Inc. bought a new position in shares of Hologic, Inc. (NASDAQ:HOLX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 67,025 shares of the medical equipment provider's stock, va
Hologic (NASDAQ:HOLX) Given Outperform Rating at William Blair
Hologic, Inc. stock logo
Hologic's (HOLX) "Outperform" Rating Reiterated at William Blair
William Blair reissued an "outperform" rating on shares of Hologic in a report on Monday.
Morgan Stanley Sticks to Their Hold Rating for Hologic (HOLX)
Hologic, Inc. stock logo
Hologic, Inc. (NASDAQ:HOLX) Stock Holdings Lifted by Clean Yield Group
Clean Yield Group increased its stake in Hologic, Inc. (NASDAQ:HOLX - Free Report) by 18.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 45,646 shares of the medical equipment provider's stock after acquiring an additio
Hologic, Inc. stock logo
Morgan Stanley Issues Pessimistic Forecast for Hologic (NASDAQ:HOLX) Stock Price
Morgan Stanley lowered their price target on shares of Hologic from $84.00 to $82.00 and set an "equal weight" rating for the company in a research report on Monday.
Hologic, Inc. stock logo
Hologic (NASDAQ:HOLX) Reaches New 12-Month Low - Should You Sell?
Hologic (NASDAQ:HOLX) Reaches New 1-Year Low - Should You Sell?
Hologic, Inc. stock logo
Needham & Company LLC Reaffirms Buy Rating for Hologic (NASDAQ:HOLX)
Needham & Company LLC restated a "buy" rating and set a $90.00 price objective on shares of Hologic in a research report on Monday.
Hologic, Inc. stock logo
Diversified Trust Co Makes New Investment in Hologic, Inc. (NASDAQ:HOLX)
Diversified Trust Co bought a new stake in Hologic, Inc. (NASDAQ:HOLX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 7,016 shares of the medical equipment provider's stock, valued at approxi
Hologic Announces Board of Directors Changes
Hologic, Inc. stock logo
First Hawaiian Bank Sells 18,933 Shares of Hologic, Inc. (NASDAQ:HOLX)
First Hawaiian Bank reduced its position in shares of Hologic, Inc. (NASDAQ:HOLX - Free Report) by 52.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 17,028 shares of the medical equipment provider's stock after selling 18
Hologic, Inc. stock logo
Nordea Investment Management AB Increases Position in Hologic, Inc. (NASDAQ:HOLX)
Nordea Investment Management AB increased its position in Hologic, Inc. (NASDAQ:HOLX - Free Report) by 32.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,213,607 shares of the medical equipment provider's stock af
Hologic Completes Acquisition of Gynesonics, Inc.
Hologic, Inc. stock logo
Zacks Research Has Bearish Outlook for Hologic Q1 Earnings
Hologic, Inc. (NASDAQ:HOLX - Free Report) - Stock analysts at Zacks Research reduced their Q1 2025 earnings estimates for Hologic in a research report issued on Tuesday, December 31st. Zacks Research analyst R. Department now forecasts that the medical equipment provider will post earnings of $1.
Hologic price target lowered to $76 from $81 at Evercore ISI
Hologic, Inc. stock logo
JPMorgan Chase & Co. Has $110.70 Million Stock Position in Hologic, Inc. (NASDAQ:HOLX)
JPMorgan Chase & Co. increased its stake in shares of Hologic, Inc. (NASDAQ:HOLX - Free Report) by 21.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,358,945 shares of the medical equipment provider
Is Hologic Stock Underperforming the Dow?
Hologic, Inc. stock logo
Principal Financial Group Inc. Increases Stock Position in Hologic, Inc. (NASDAQ:HOLX)
Principal Financial Group Inc. boosted its holdings in Hologic, Inc. (NASDAQ:HOLX - Free Report) by 3.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 269,546 shares of the medical equipment provider's st
Hologic, Inc. stock logo
Hologic, Inc. (NASDAQ:HOLX) Receives Consensus Rating of "Moderate Buy" from Analysts
Hologic, Inc. (NASDAQ:HOLX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the fifteen analysts that are covering the company, MarketBeat.com reports. Six analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong
Hologic, Inc. stock logo
Hologic, Inc. (NASDAQ:HOLX) Shares Acquired by Stifel Financial Corp
Stifel Financial Corp increased its holdings in Hologic, Inc. (NASDAQ:HOLX - Free Report) by 115.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,354 shares of the medical equipment provider's stock after acquiring
Hologic, Inc. stock logo
Hologic (NASDAQ:HOLX) Hits New 52-Week Low - Time to Sell?
Hologic (NASDAQ:HOLX) Hits New 52-Week Low - Time to Sell?
Hologic, Inc. stock logo
Hologic, Inc. (NASDAQ:HOLX) Stock Holdings Boosted by Franklin Resources Inc.
Franklin Resources Inc. raised its position in Hologic, Inc. (NASDAQ:HOLX - Free Report) by 171.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 278,295 shares of the medical equipment provider's stock after purchasing an
Hologic, Inc. stock logo
Hologic's (HOLX) "Buy" Rating Reiterated at Needham & Company LLC
Needham & Company LLC reiterated a "buy" rating and set a $90.00 price objective on shares of Hologic in a research report on Thursday.
Hologic recalls BioZorb Marker over safety concerns
Hologic recalls BioZorb Marker over safety concerns
Hologic enters agreement with CDC to develop ASRs
Get Hologic News Delivered to You Automatically

Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter.

HOLX Media Mentions By Week

HOLX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HOLX
News Sentiment

0.35

0.44

Average
Medical
News Sentiment

HOLX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HOLX Articles
This Week

19

9

HOLX Articles
Average Week

Get Hologic News Delivered to You Automatically

Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:HOLX) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners